Page header
Introduction text
Toggle
1985
Medis founded
2003
First major launch into European market: RAMIPRIL
2008
Total number of sold units reaches 3 billion
2012
Medis and "Specifar" Greece combine third party businesses
2013
"Spirit" Australia combined third party business with medis
2015
30th Anniversary of Medis
Medis wins ‘Business Development of the Year’ at Global Generics & Biosimilar Awards. Pregabalin, where Medis’ customers were first to launch the product in both the UK and Germany
2016
Teva Pharmaceuticals Ltd acquires Actavis Generics, including Medis
Medis & Teva IB Spain combine the third party business
2017
Medis wins Company of the Year
EMEA award at the Global Generics & Biosmilars Awards 2017